162 related articles for article (PubMed ID: 38417838)
1. Esketamine inhibits the c-Jun N-terminal kinase pathway in the spinal dorsal horn to relieve bone cancer pain in rats.
Duan C; Zhu Y; Zhang Z; Wu T; Shen M; Xu J; Gao W; Pan J; Wei L; Su H; Shi C
Mol Pain; 2024; 20():17448069241239231. PubMed ID: 38417838
[TBL] [Abstract][Full Text] [Related]
2. CXCL12 in astrocytes contributes to bone cancer pain through CXCR4-mediated neuronal sensitization and glial activation in rat spinal cord.
Shen W; Hu XM; Liu YN; Han Y; Chen LP; Wang CC; Song C
J Neuroinflammation; 2014 Apr; 11():75. PubMed ID: 24735601
[TBL] [Abstract][Full Text] [Related]
3. CXCL12/CXCR4 chemokine signaling in spinal glia induces pain hypersensitivity through MAPKs-mediated neuroinflammation in bone cancer rats.
Hu XM; Liu YN; Zhang HL; Cao SB; Zhang T; Chen LP; Shen W
J Neurochem; 2015 Feb; 132(4):452-63. PubMed ID: 25393328
[TBL] [Abstract][Full Text] [Related]
4. JNK in spinal cord facilitates bone cancer pain in rats through modulation of CXCL1.
Wang ZL; Du TT; Zhang RG
J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):88-94. PubMed ID: 26838746
[TBL] [Abstract][Full Text] [Related]
5. Chemokine receptor CXCR4 activates the RhoA/ROCK2 pathway in spinal neurons that induces bone cancer pain.
Xu H; Peng C; Chen XT; Yao YY; Chen LP; Yin Q; Shen W
Mol Pain; 2020; 16():1744806920919568. PubMed ID: 32349612
[TBL] [Abstract][Full Text] [Related]
6. Down-Regulation of CXCL12/CXCR4 Expression Alleviates Ischemia-Reperfusion-Induced Inflammatory Pain via Inhibiting Glial TLR4 Activation in the Spinal Cord.
Li XQ; Zhang ZL; Tan WF; Sun XJ; Ma H
PLoS One; 2016; 11(10):e0163807. PubMed ID: 27760212
[TBL] [Abstract][Full Text] [Related]
7. CXCL12 induces connective tissue growth factor expression in human lung fibroblasts through the Rac1/ERK, JNK, and AP-1 pathways.
Lin CH; Shih CH; Tseng CC; Yu CC; Tsai YJ; Bien MY; Chen BC
PLoS One; 2014; 9(8):e104746. PubMed ID: 25121739
[TBL] [Abstract][Full Text] [Related]
8. CXCL12/CXCR4 signaling contributes to neuropathic pain via central sensitization mechanisms in a rat spinal nerve ligation model.
Liu ZY; Song ZW; Guo SW; He JS; Wang SY; Zhu JG; Yang HL; Liu JB
CNS Neurosci Ther; 2019 Sep; 25(9):922-936. PubMed ID: 30955244
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Chemokine CXCL12 in the Dorsal Root Ganglia and Spinal Cord Contributes to the Development and Maintenance of Neuropathic Pain Following Spared Nerve Injury in Rats.
Bai L; Wang X; Li Z; Kong C; Zhao Y; Qian JL; Kan Q; Zhang W; Xu JT
Neurosci Bull; 2016 Feb; 32(1):27-40. PubMed ID: 26781879
[TBL] [Abstract][Full Text] [Related]
10. CXCL12/CXCR4 signaling mediated ERK1/2 activation in spinal cord contributes to the pathogenesis of postsurgical pain in rats.
Xing F; Kong C; Bai L; Qian J; Yuan J; Li Z; Zhang W; Xu JT
Mol Pain; 2017; 13():1744806917718753. PubMed ID: 28633557
[TBL] [Abstract][Full Text] [Related]
11. Activation of c-jun N-terminal kinase in spinal cord contributes to breast cancer induced bone pain in rats.
Wang XW; Hu S; Mao-Ying QL; Li Q; Yang CJ; Zhang H; Mi WL; Wu GC; Wang YQ
Mol Brain; 2012 Jun; 5():21. PubMed ID: 22681856
[TBL] [Abstract][Full Text] [Related]
12. Chemokine receptor CXCR4 regulates CaMKII/CREB pathway in spinal neurons that underlies cancer-induced bone pain.
Hu XM; Zhang H; Xu H; Zhang HL; Chen LP; Cui WQ; Yang W; Shen W
Sci Rep; 2017 Jun; 7(1):4005. PubMed ID: 28638088
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between astrocytic CXCL12 and microglial CXCR4 contributes to the development of neuropathic pain.
Luo X; Tai WL; Sun L; Pan Z; Xia Z; Chung SK; Cheung CW
Mol Pain; 2016; 12():. PubMed ID: 27030717
[TBL] [Abstract][Full Text] [Related]
14. Curcumin analogue NL04 inhibits spinal cord central sensitization in rats with bone cancer pain by inhibiting NLRP3 inflammasome activation and reducing IL-1β production.
Chen L; Hua B; He Q; Han Z; Wang Y; Chen Y; Ni H; Zhu Z; Xu L; Yao M; Ni C
Eur J Pharmacol; 2024 May; 970():176480. PubMed ID: 38490468
[TBL] [Abstract][Full Text] [Related]
15. Astrocyte activation in the periaqueductal gray promotes descending facilitation to cancer-induced bone pain through the JNK MAPK signaling pathway.
Ni HD; Xu LS; Wang Y; Li H; An K; Liu M; Liu Q; Deng H; He Q; Huang B; Fang J; Yao M
Mol Pain; 2019; 15():1744806919831909. PubMed ID: 30700204
[TBL] [Abstract][Full Text] [Related]
16. Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms.
Daulhac L; Mallet C; Courteix C; Etienne M; Duroux E; Privat AM; Eschalier A; Fialip J
Mol Pharmacol; 2006 Oct; 70(4):1246-54. PubMed ID: 16868181
[TBL] [Abstract][Full Text] [Related]
17. Ligustilide Relieves Complete Freund's Adjuvant-induced Mechanical Hyperalgesia through Inhibiting the Activation of Spinal c-Jun N-terminal Kinase/c-Jun Pathway in Rats.
Wang YR; Xu H; Tao M; Xu LH; Fu XC
Pharmacogn Mag; 2017; 13(52):634-638. PubMed ID: 29200725
[TBL] [Abstract][Full Text] [Related]
18. The analgesic effect of rolipram is associated with the inhibition of the activation of the spinal astrocytic JNK/CCL2 pathway in bone cancer pain.
Guo CH; Bai L; Wu HH; Yang J; Cai GH; Wang X; Wu SX; Ma W
Int J Mol Med; 2016 Nov; 38(5):1433-1442. PubMed ID: 28025994
[TBL] [Abstract][Full Text] [Related]
19. Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain.
Wang W; Mei XP; Wei YY; Zhang MM; Zhang T; Wang W; Xu LX; Wu SX; Li YQ
Brain Behav Immun; 2011 Oct; 25(7):1355-66. PubMed ID: 21496481
[TBL] [Abstract][Full Text] [Related]
20. AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.
Liao YX; Fu ZZ; Zhou CH; Shan LC; Wang ZY; Yin F; Zheng LP; Hua YQ; Cai ZD
Oncol Rep; 2015 Jul; 34(1):33-42. PubMed ID: 25997540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
